These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9626160)
1. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. Mitsiades N; Poulaki V; Kotoula V; Mastorakos G; Tseleni-Balafouta S; Koutras DA; Tsokos M J Clin Endocrinol Metab; 1998 Jun; 83(6):2199-203. PubMed ID: 9626160 [TBL] [Abstract][Full Text] [Related]
2. [Expression of apoptosis-related proteins in Hashimoto's thyroiditis and its pathological significance]. Zhang Y; Ji Q; Zhang W Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):432-4. PubMed ID: 11798914 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders. Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172 [TBL] [Abstract][Full Text] [Related]
4. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases. Xu WC; Chen SR; Huang JX; Zheng ZC; Chen LX; Lin JJ; Li YG Eur J Histochem; 2007; 51(4):291-300. PubMed ID: 18162459 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614 [TBL] [Abstract][Full Text] [Related]
7. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310 [TBL] [Abstract][Full Text] [Related]
8. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis. Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486 [TBL] [Abstract][Full Text] [Related]
9. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. Hammond LJ; Lowdell MW; Cerrano PG; Goode AW; Bottazzo GF; Mirakian R J Pathol; 1997 Jun; 182(2):138-44. PubMed ID: 9274522 [TBL] [Abstract][Full Text] [Related]
10. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. Stassi G; Todaro M; Bucchieri F; Stoppacciaro A; Farina F; Zummo G; Testi R; De Maria R J Immunol; 1999 Jan; 162(1):263-7. PubMed ID: 9886394 [TBL] [Abstract][Full Text] [Related]
11. [The role of apoptosis in the etiopathogenesis of autoimmune thyroiditis]. Łacka K; Maciejewski A Pol Merkur Lekarski; 2012 Feb; 32(188):87-92. PubMed ID: 22590910 [TBL] [Abstract][Full Text] [Related]
12. Is lymphocytic thyroiditis a unique type or merely a type of Hashimoto's thyroiditis? Todorovic J; Nesovic Ostojic J; Opric D; Dundjerovic D; Bozic V; Markovic L Minerva Med; 2014 Aug; 105(4):303-12. PubMed ID: 24867187 [TBL] [Abstract][Full Text] [Related]
13. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers. Myśliwiec J; Okota M; Nikołajuk A; Górska M Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290 [TBL] [Abstract][Full Text] [Related]
14. The role of apoptosis in thyroid disease. Tsatsoulis A Minerva Med; 2002 Jun; 93(3):169-80. PubMed ID: 12094148 [TBL] [Abstract][Full Text] [Related]
15. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis]. Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711 [TBL] [Abstract][Full Text] [Related]
16. Thyrocyte targets and effectors of autoimmunity: a role for death receptors? Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038 [TBL] [Abstract][Full Text] [Related]
17. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Giordano C; Stassi G; De Maria R; Todaro M; Richiusa P; Papoff G; Ruberti G; Bagnasco M; Testi R; Galluzzo A Science; 1997 Feb; 275(5302):960-3. PubMed ID: 9020075 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases]. Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722 [TBL] [Abstract][Full Text] [Related]
19. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family. Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827 [TBL] [Abstract][Full Text] [Related]
20. Functional Fas ligand expression in thyrocytes from patients with Graves' disease. Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]